| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.33 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |